Production (Stage)
GoHealth, Inc.
GOCO
$5.75
-$0.01-0.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.18% | 8.74% | 30.17% | 32.52% | 35.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.18% | 8.74% | 30.17% | 32.52% | 35.44% |
| Cost of Revenue | -12.96% | -17.83% | -13.75% | -9.82% | -8.29% |
| Gross Profit | 19.94% | 16.08% | 45.82% | 49.40% | 54.50% |
| SG&A Expenses | 9.21% | 5.94% | 2.82% | 0.98% | 1.37% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.84% | -0.06% | -1.10% | -1.35% | -0.66% |
| Operating Income | 113.57% | 93.74% | 73.77% | 76.58% | 75.18% |
| Income Before Tax | 105.12% | 96.66% | 77.53% | 56.29% | 58.51% |
| Income Tax Expenses | 2,608.66% | 1,372.08% | 283.58% | -8.57% | -48.79% |
| Earnings from Continuing Operations | 102.83% | 95.16% | 77.45% | 56.26% | 58.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -102.72% | -95.01% | -78.49% | -58.22% | -60.06% |
| Net Income | 102.97% | 95.37% | 75.97% | 53.41% | 56.17% |
| EBIT | 113.57% | 93.74% | 73.77% | 76.58% | 75.18% |
| EBITDA | 229.15% | 222.83% | 130.08% | 130.71% | 119.95% |
| EPS Basic | 97.01% | 89.80% | 75.88% | 55.60% | 57.50% |
| Normalized Basic EPS | -1,980.92% | -3,124.21% | -338.67% | 72.06% | -86.93% |
| EPS Diluted | 82.48% | 75.48% | 75.06% | 55.60% | 57.51% |
| Normalized Diluted EPS | -1,441.55% | -2,310.81% | -195.53% | 72.06% | -86.93% |
| Average Basic Shares Outstanding | 7.04% | 7.43% | 7.89% | 8.24% | 8.37% |
| Average Diluted Shares Outstanding | 35.32% | 36.28% | 20.23% | 8.24% | 8.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -0.39% | -1.15% | -5.84% |